Psychotropic medication use among patients with a traumatic brain injury treated in the intensive care unit: a multi-centre observational study.
Intensive care
Psychiatric sequelae
Psychotropic medication
Traumatic brain injury
Journal
Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
26
04
2021
accepted:
26
07
2021
pubmed:
12
8
2021
medline:
25
11
2021
entrez:
11
8
2021
Statut:
ppublish
Résumé
Psychiatric sequelae after traumatic brain injury (TBI) are common and may impede recovery. We aimed to assess the occurrence and risk factors of post-injury psychotropic medication use in intensive care unit (ICU)-treated patients with TBI and its association with late mortality. We conducted a retrospective multi-centre observational study using the Finnish Intensive Care Consortium database. We included adult TBI patients admitted in four university hospital ICUs during 2003-2013 that were alive at 1 year after injury. Patients were followed-up until end of 2016. We obtained data regarding psychotropic medication use through the national drug reimbursement database. We used multivariable logistic regression models to assess the association between TBI severity, treatment-related variables and the odds of psychotropic medication use and its association with late all-cause mortality (more than 1 year after TBI). Of 3061 patients, 2305 (75%) were alive at 1 year. Of these, 400 (17%) became new psychotropic medication users. The most common medication types were antidepressants (61%), antipsychotics (35%) and anxiolytics (26%). A higher Glasgow Coma Scale (GCS) score was associated with lower odds (OR 0.93, 95% CI 0.90-0.96) and a diffuse injury with midline shift was associated with higher odds (OR 3.4, 95% CI 1.3-9.0) of new psychotropic medication use. After adjusting for injury severity, new psychotropic medication use was associated with increased odds of late mortality (OR 1.19, 95% CI 1.19-2.17, median follow-up time 6.4 years). Psychotropic medication use is common in TBI survivors. Higher TBI severity is associated with increased odds of psychotropic medication use. New use of psychotropic medications after TBI was associated with increased odds of late mortality. Our results highlight the need for early identification of potential psychiatric sequelae and psychiatric evaluation in TBI survivors.
Sections du résumé
BACKGROUND
Psychiatric sequelae after traumatic brain injury (TBI) are common and may impede recovery. We aimed to assess the occurrence and risk factors of post-injury psychotropic medication use in intensive care unit (ICU)-treated patients with TBI and its association with late mortality.
METHODS
We conducted a retrospective multi-centre observational study using the Finnish Intensive Care Consortium database. We included adult TBI patients admitted in four university hospital ICUs during 2003-2013 that were alive at 1 year after injury. Patients were followed-up until end of 2016. We obtained data regarding psychotropic medication use through the national drug reimbursement database. We used multivariable logistic regression models to assess the association between TBI severity, treatment-related variables and the odds of psychotropic medication use and its association with late all-cause mortality (more than 1 year after TBI).
RESULTS
Of 3061 patients, 2305 (75%) were alive at 1 year. Of these, 400 (17%) became new psychotropic medication users. The most common medication types were antidepressants (61%), antipsychotics (35%) and anxiolytics (26%). A higher Glasgow Coma Scale (GCS) score was associated with lower odds (OR 0.93, 95% CI 0.90-0.96) and a diffuse injury with midline shift was associated with higher odds (OR 3.4, 95% CI 1.3-9.0) of new psychotropic medication use. After adjusting for injury severity, new psychotropic medication use was associated with increased odds of late mortality (OR 1.19, 95% CI 1.19-2.17, median follow-up time 6.4 years).
CONCLUSIONS
Psychotropic medication use is common in TBI survivors. Higher TBI severity is associated with increased odds of psychotropic medication use. New use of psychotropic medications after TBI was associated with increased odds of late mortality. Our results highlight the need for early identification of potential psychiatric sequelae and psychiatric evaluation in TBI survivors.
Identifiants
pubmed: 34379205
doi: 10.1007/s00701-021-04956-3
pii: 10.1007/s00701-021-04956-3
pmc: PMC8437905
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2909-2917Informations de copyright
© 2021. The Author(s).
Références
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Crit Care Med. 2018 Apr;46(4):e302-e309
pubmed: 29293155
Am J Psychiatry. 1993 Jun;150(6):916-21
pubmed: 8494069
Am J Geriatr Psychiatry. 2017 Apr;25(4):415-424
pubmed: 28111062
J Hosp Med. 2017 Oct;12(10):831-835
pubmed: 28991949
Psychosomatics. 2006 May-Jun;47(3):223-30
pubmed: 16684939
Brain Inj. 1996 May;10(5):319-27
pubmed: 8735663
Arch Gen Psychiatry. 2005 Jul;62(7):742-9
pubmed: 15997015
Psychol Med. 2001 Feb;31(2):231-9
pubmed: 11232911
J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):130-40
pubmed: 11983787
Crit Care Med. 2016 Sep;44(9):1744-53
pubmed: 27153046
J Head Trauma Rehabil. 2009 Sep-Oct;24(5):324-32
pubmed: 19858966
Am J Psychiatry. 1999 Mar;156(3):374-8
pubmed: 10080551
Crit Care Med. 2015 May;43(5):1121-9
pubmed: 25654178
J Neurotrauma. 2012 Apr 10;29(6):1029-37
pubmed: 22111890
Cogn Behav Neurol. 2004 Jun;17(2):118-20
pubmed: 15453521
Lancet Neurol. 2019 Jan;18(1):56-87
pubmed: 30497965
Am J Psychiatry. 1995 Oct;152(10):1493-9
pubmed: 7573589
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
J Neuropsychiatry Clin Neurosci. 2000 Summer;12(3):316-27
pubmed: 10956565
J Trauma. 2008 Apr;64(4):876-82
pubmed: 18404051
Biol Psychiatry. 2007 Aug 15;62(4):332-8
pubmed: 17123480
Acta Anaesthesiol Scand. 2012 Oct;56(9):1114-22
pubmed: 22384799
Gen Hosp Psychiatry. 2016 Nov - Dec;43:23-29
pubmed: 27796253
Neuropsychiatr Dis Treat. 2008 Aug;4(4):797-816
pubmed: 19043523
Br J Psychiatry. 2015 Sep;207(3):221-6
pubmed: 26159603
J Psychosom Res. 1997 Oct;43(4):335-43
pubmed: 9330232
J Head Trauma Rehabil. 2007 Jan-Feb;22(1):1-13
pubmed: 17235226
Arch Gen Psychiatry. 2004 Jan;61(1):53-61
pubmed: 14706944
Arch Phys Med Rehabil. 2015 Aug;96(8 Suppl):S256-3.e14
pubmed: 26212402
Arch Gen Psychiatry. 2004 Jan;61(1):42-50
pubmed: 14706943
Brain Inj. 2018;32(13-14):1591-1600
pubmed: 30373405
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Arch Phys Med Rehabil. 2004 Sep;85(9):1457-64
pubmed: 15375816
Crit Care Med. 1983 Jan;11(1):1-3
pubmed: 6848305
Am J Psychiatry. 2002 Aug;159(8):1315-21
pubmed: 12153823